EQT能源（EQT）在周日夜盘交易中大幅上涨7.30%，引发市场广泛关注。
根据最新消息，EQT正参与竞购印度知名制药上市公司Gland Pharma的控股权。据印度《经济时报》报道，包括EQT在内的四家国际私募股权巨头正在就收购复星国际旗下的Gland Pharma进行磋商，整体估值约30亿美元。EQT已成功入围第一轮竞价，这可能是推动其股价大幅上涨的主要原因。
Gland Pharma被誉为"注射剂之王"，是印度第一家获得美国FDA批准的注射剂药品生产制造企业。如果EQT成功收购，将获得51.83%的控股权，交易对价约为15.55亿美元。这笔收购不仅将使EQT进入印度制药市场，还可能带来可观的投资回报。投资者对EQT参与如此重大的收购案表现出积极态度，这反映在其股价的显著上涨上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.